Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT03961659 Recruiting - Obesity Clinical Trials

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Start date: May 2019
Phase: N/A
Study type: Interventional

This is a prospective, randomized, open label, parallel, 16-week study to explore and evaluate the therapeutic effects of liraglutid, dapagliflozin and acarbose on the cognitive function, olfactory function, and odor-induced brain activation in overweight/obese patients with type 2 diabetes mellitus(T2DM) inadequately controlled with metformin monotherapy.

NCT ID: NCT03960476 Active, not recruiting - Alzheimer Disease Clinical Trials

Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults

Start date: January 13, 2020
Phase: N/A
Study type: Interventional

This study seeks to better understand how older adult aging-in-place/long term care decision making and implementation is impacted by age-related changes (e.g. cognition, health literacy, chronic conditions), social influences (e.g. caregivers/supporters), and environmental factors.

NCT ID: NCT03954899 Recruiting - Clinical trials for Mild Cognitive Impairment

Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging

Start date: November 12, 2019
Phase: N/A
Study type: Interventional

The study will examine whether 5mg melatonin (over the counter, OTC) over a 9-month period improves Alzheimer's disease (AD) biomarkers and cognitive function in two groups of individuals: those with mild cognitive impairment (MCI+) and those who are not (MCI-). AD biomarkers will be measured from cerebrospinal fluid (CSF) obtained from lumbar punctures. Cognitive function will be evaluated with routine neuropsychological tests.

NCT ID: NCT03954340 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

BestBrain Evaluation of Cognitive Memory & Executive-Function

BECOME
Start date: December 11, 2019
Phase: N/A
Study type: Interventional

This study is intended 1. To quantify the effects of the iRemember personalized EEG-NFB therapy on working memory and executive functions in subjects with MCI by calculating the percentage of change in the Neurotrax tests performed prior to and after the treatment, and compare the results between the active treatment and placebo cohorts

NCT ID: NCT03953313 Completed - Clinical trials for Post-operative Delirium

Risk Communication About Post-operative Delirium (POD) and Post-operative Cognitive Dysfunction (POCD)

Start date: May 3, 2021
Phase:
Study type: Observational

The purpose of this study is to assess the awareness of post-operative delirium (POD) and post-operative cognitive dysfunction (POCD), their respective risk factors and effective preparation and treatment options in a pre-clinical sample of patients attending a premedication outpatient clinic (Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany) prior to elective surgery. The investigators hypothesize that the awareness for POD/POCD as potential risk in consequence of the surgery is very low in patients, and that therefore easy to use measure for prevention are underutilized by patients.

NCT ID: NCT03952208 Active, not recruiting - Concussion, Brain Clinical Trials

Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion

Start date: February 21, 2019
Phase: N/A
Study type: Interventional

Researchers are trying to determine if the impact of a concussion on the brain is affected by anesthesia and surgery.

NCT ID: NCT03951246 Completed - Clinical trials for Cognitive Impairment

Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors

Start date: November 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to create a rehabilitation program for children who survived posterior fossa tumors using the latest technology. Supposed that training in Fitlight, Dynavision D2, NeuroTracker will improve executive functions, visual-motor integration, fine and gross motor functions.

NCT ID: NCT03950557 Not yet recruiting - Emergence Delirium Clinical Trials

Post Operative Cognitive Dysfunction and Delirium After Spinal Surgery

Start date: July 1, 2019
Phase:
Study type: Observational

Aim of this trial is to define if Post-Operative Cognitive Dysfunction and Delirium, detected analyzing changes between pre-operative and post-operative Neurocognitive Test, relate to concentration of effector's site concentration of propofol and remifentanil TCI and to the common intraoperative neuromonitoring values.

NCT ID: NCT03949322 Recruiting - Clinical trials for Patients Treated for Cancer

Cancer Related Cognitive Impairment

APACO
Start date: February 28, 2019
Phase: N/A
Study type: Interventional

Various recent scientific data testify to the cognitive deficiencies of cancer patients, called Cancer-Related Cognitive Impairments (CRCI) (Noal, Daireaux & Joly, 2010). At the same time, regular physical activity (aerobic, muscle building, and yoga) has been shown to decrease CRCIs, although commonly used cognitive measures are self-reported (Zimmer et al., 2016). The investigators will develop an interventional study using objective measures of cognition to confirm the cause-and-effect relationship, and specify the orientation of the cognitive effects of the adapted physical activities. The main and original objective will be to determine if the cognitive functions most affected by CRCI (episodic memory, inhibition, treatment speed) can be optimized in patients undergoing treatment.

NCT ID: NCT03947671 Withdrawn - Cardiac Surgery Clinical Trials

Active Temperature Management After Cardiac Surgery and Its Effect on Postoperative Cognitive Dysfunction

Start date: January 22, 2020
Phase: Phase 2
Study type: Interventional

This study will assess the effect of active postoperative temperature management and its effect on the cognitive function in patients following coronary artery bypass graft (CABG) surgery to determine if active postoperative temperature management to maintain normothermia reduces postoperative cognitive dysfunction (POCD) in this population. Additionally, the investigators will explore differences in temperature control variability by using temperature management wraps combined with acetaminophen vs. acetaminophen alone in a pilot arm.